QR-Code

The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

<p>Abstract</p> <p>Background</p> <p>Several classification systems are available to assess pathological response to neoadjuvant chemotherapy in breast cancer, but reliable biomarkers to predict the efficiency of primary systemic therapy (PST) are still missing. Deregulation of gap junction channel...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Teleki Ivett, Krenacs Tibor, Szasz Marcell A, Kulka Janina, Wichmann Barna, Leo Cornelia, Papassotiropoulos Barbel, Riemenschnitter Cosima, Moch Holger, Varga Zsuzsanna
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2013-02-01
Schriftenreihe:BMC Cancer
Schlagworte:
Online-Zugang:http://www.biomedcentral.com/1471-2407/13/50
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!